GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Evotec EVT.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

2.51

-8.06%

Close of 20 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Evotec — daily XETR:EVT End of day
Market value
€445.0m
Last close × shares
Volume
2.7m
Shares, 20 Nov 2026

About Evotec

Its shares trade on XETRA under the ticker EVT.DE. It has been listed since 11 October 1999. In the fiscal year to 31 December 2025, it reported revenue of €788.4m and a net loss of €103.5m. At that date it held total assets of €1.78bn and shareholders' equity of €813.7m.

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. The company is headquartered in Hamburg, Hamburg. The firm is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Evotec →

Latest on Evotec

Our reporting

Next results

14 Apr 2027

Due on 14 Apr 2027. Analysts expect earnings of -0.24 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Evotec's ticker?

Evotec trades as EVT.DE on XETRA, under ISIN DE0005664809.

What was Evotec's last closing price?

2.51 on 20 Nov 2026. The figure is in EUR and is never converted.

When does Evotec next report results?

Results are expected on 5 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.